ISPE Indonesia

ISPE Indonesia: Annual Conference 8 Mei 2018 di Jakarta

ISPE Indonesia akan kembali menyelenggarakan Annual Conference 2018 yang akan berlangsung pada tanggal 8 – 9 May 2018 di Hotel Holiday Inn, Kemayoran, Jakarta.

Tema tahun ini adalah BEYOND COMPLIANCE – Protecting Patients, Support Innovation dan akan menampilkan Regulator dan pembicara yang ahli dalam bidangnya baik dari Indonesia maupun global.

Dalam Conference juga akan dibahas mengenai Serialization, topik yang sedang viral dengan rencana BPOM untuk menerapkan di Indonesia dalam waktu yang tidak lama lagi, dan akan dibahas dari berbagai sudut pandang.

Selain itu juga akan dibahas mengenai pengetahuan untuk industri Farmasi baik yang saat ini menjadi tren maupun arah masa depan industri Farmasi yang tentunya akan sangat bermanfaat bagi Bapak dan Ibu sekalian

Bersama ini kami lampirkan softcopy flyer &; tentative agenda ISPE Annual Conference 2018 untuk mendapatkan info mengenai Pembicara, Materi/Topik yang akan bicarakan dan informasi lainnya. Untuk Registrasi online dapat diakses melalui link http://pharma-pro.co.id/ispe-annconf/Registration_Form.php

Pendaftaran dan pertanyaan dapat dilakukan melalui Sekretariat ISPE Indonesia Annual Conference di bawah ini :

ISPE INDONESIA CONFERENCE SECRETARIAT: Ms. Sari Rosaliana, Komplek Perkantoran Duta Merlin Blok C/35-36, Jl. Gajah Mada 3-5, Jakarta 10130, Phone: +6221-63869502
Fax: +6221-63869502/05, Mobile: +6857.1113.2772 (Ms. Sari), Email: ispeind.annconf@pharma-pro.com or sari.rosalina@pharma-pro.com

Pembicara:

Norikazu Eiki In 1979 he joined to Ciba-Geigy Japan Co., Ltd. Since joining Bayer Japan in 1994, he took over as Bayer Pharmaceutical Director and Shiga Plant Manager since 1997. From 2002 to 2006, he was the President and Representative Director of the company, from 2007 until 2014 Representative Director and Chairman of the company.

Meanwhile, he served as a member of the Japan Pharmaceutical Manufacturers Association Association, the Japan Heart Foundation Board Member, the Osaka Pharmaceutical Association Board Member, the Japan PDA Board Member, and the ISPE International Member. AAfter retiring from Bayer in 2014, he moved to NJ USA and belongs to the New York Consulting ABPS Group.

Vee (Vasiliki) REVITHI studied Chemistry and holds a PhD in Biochemistry (with distinction). She has worked for 36 years in EOF (1976 to 2012), the Medicines Authority of Greece, in various positions (laboratories, regulatory departments and mainly GMP & GDP inspections). She has been Head of Division for more than 14 years of her career, 10 of them as Head of the GMDP Inspectorate of the Agency.

She joined Roche in Basel, Switzerland in June 2013 in the unit of External Relations Europe in PTQG. She has led the implementation of a Quality System according to EU, Pharmaceutical Inspectorates Cooperation Scheme (PIC/S) and ISO 17020 requirements in the Greek GMDP Inspectorate, the implementation of EU and PIC/S Inspections methodology and the accession of EOF/Greece to PIC/S in 2002.

Mr Vimal Sachdeva had been working as an inspector with the WHO PQT (for medicines, vaccines, IVDs and diagnostics) since year 2010, based in Geneva, Switzerland. Mr Sachdeva has had more than 26 years of pharmaceutical industry experience including 15 years as a regulator. Before joining WHO, Mr Sachdeva worked with the Singapore Health Sciences Authority a Senior GMP Auditor and Senior Regulatory Specialist.

Since he joined WHO PQT, Mr Sachdeva has led inspections of facilities manufacturing Active Pharmaceutical Ingredients (APIs) and Finished Pharmaceutical Products (FPPs), Contract Research Organizations (CROs) and National Pharmaceutical Quality Control Laboratories. To-date, he has performed more than 200 inspections in Asia, Africa, Latin America and North America.

ISPE Indonesia
x